glp-1 gip vs tirzepatide The dual agonist action of on various organs. GLP-1: glp-1 vs tirzepatide Semaglutide |

23 Importantly, Mazdutide, a GLP-1/GCGR dual agonist, has shown promising outcomes in recent clinical trials, offering a unique mechanism that enhances fat oxidation, energy expenditure, and liver-fat reduction

Its approval for obesity treatment has broadened its market appeal, especially as global obesity rates rise

On the other hand, semaglutide is a newer medication that is approved for weight loss and diabetes management

American Diabetes Association Professional Practice Committee, Nuha A

X.ZhangL

The slides were washed three times with PBS, followed by fixation in 500 L of 4% paraformaldehyde for 15 min at room temperature